Patent Assignment
Reel/Frame 044127/0229
Address Change
Recorded: 2017-10-04
Pages: 5
Assignor
TACT IP, LLC
Executed: 2017-09-25
Assignee
TACT IP, LLC
1877 S. FEDERAL HWY, SUITE 110, BOCA RATON, FLORIDA, 33432
Covered Properties
(44)
Apparatus and Method Employing Lasers for Removal of Hair, Veins and Capillaries
Patent:
6,165,171 →
Application:
09/054,570 →
Apparatus and Method Employing Lasers for Removal of Hair, Veins and Capillaries
Patent:
6,149,645 →
Application:
09/054,571 →
Apparatus and Method Employing a Single Laser for Removal of Hair, Veins and Capillaries
Patent:
6,168,589 →
Application:
09/054,574 →
Apparatus and Method Employing Lasers for Removal of Hair, Veins and Capillaries
Patent:
6,217,572 →
Application:
09/083,481 →
Apparatus and Method Employing a Single Laser for Removal of Hair, Veins and Capillaries
Patent:
6,579,283 →
Application:
09/083,482 →
Method of Employing a Flashlamp for Removal of Hair, Veins and Capillaries
Patent:
6,080,147 →
Application:
09/095,630 →
Tumor Necrosis Factors Antagonists for the Treatment of Neurological Disorders
Application:
09/256,388 →
Tumor Necrosis Factor Antagonists for the Treatment of Neurological Disorders
Patent:
6,015,557 →
Application:
09/275,070 →
Apparatus and Method Employing Parametrically Defined Pulse Groups for Laser Hair Removal
Patent:
6,595,985 →
Application:
09/415,303 →
Tnf Inhibitors for the Treatment of Neurological
Patent:
6,177,077 →
Application:
09/476,643 →
Interleukin Antagonists for the Treatment of Neurological, Retinal and Muscular Disorders
Patent:
6,471,961 →
Application:
09/563,651 →
Tnf Modulators for Treating Neurological Disorders Associated with Viral Infection
Patent:
6,419,934 →
Application:
09/654,996 →
Tnf Inhibitors for the Treatment of Retinal Disorders
Patent:
6,428,787 →
Application:
09/665,529 →
Tnf Inhibitors for the Treatment of Neurological, Retinal and Muscular Disorders
Patent:
6,379,666 →
Application:
09/666,068 →
Cytokine Antagonists for the Treatment of Sensorineural Hearing Loss
Cytokine Antagonists for the Treatment of Localized Disorders
Cytokine Antagonists for the Treatment of Localized Disorders
Interleukin antagonists for the treatment of neurological, retinal and muscular disorders
Application:
10/152,476 →
Publication:
US 2002/0131954
Interleukin Antagonists for the Treatment of Neurological, Retinal and Muscular Disorders
Cytokine antagonists and other biologics for the treatment of bone metastases
Application:
10/236,097 →
Publication:
US 2003/0007972
Cytokine Antagonists for Neurological and Neuropsychiatric Disorders
TNF inhibition for the treatment of pre-menstrual syndrome and primary dysmenorrhea
Application:
10/340,890 →
Publication:
US 2003/0113318
Cytokine antagonists for the treatment of localized disorders
Application:
10/393,540 →
Publication:
US 2003/0185826
Method of Delivering a Tnf Antagonist to the Brain of a Human by Perispinal Administration Without Direct Intrathecal Injection
Cytokine Antagonists for Neurological and Neuropsychiatric Disorders
Methods to Facilitate Transmission of Large Molecules Across the Blood-Brain, Blood-Eye, and Blood-Nerve Barriers
Methods of perispinal extrathecal administration of large molecules for diagnostic use in mammals
Application:
11/986,423 →
Publication:
US 2009/0130019
Methods of Inhibiting the Action of Tnf for Neurological Conditions by Administering Etanercept Intrathecally
Patent:
45,976 →
Application:
12/344,437 →
Tnf Inhibitors for the Treatment of Neurological Disorders
Application:
12/344,452 →
Tnf Modulators for Treating Neurological Disorders Associated with Viral Infection
Application:
12/346,737 →
Methods to Facilitate Transmission of Large Molecules Across the Blood-Brain, Blood-Eye, and Blood-Nerve Barriers
Cytokine Antagonists for Neurological and Neuropsychiatric Disorders
Application:
12/714,205 →
Publication:
US 2010/0150933
Cytokine Antagonists for Neurological and Neuropsychiatric Disorders
Methods to Facilitate Transmission of Large Molecules Across the Blood-Brain, Blood-Eye, and Blood-Nerve Barriers
Application:
13/556,151 →
Publication:
US 2013/0022540
Cytokine Antagonists for Neurological and Neuropsychiatric Disorders
Application:
13/732,892 →
Publication:
US 2013/0115211
Methods for Treatment of Brain Injury Utilizing Biologics
Methods for Treatment of Brain Injury Utilizing Biologics
Etanercept for treatment or prevention of cognitive impairment, alzheimer's disease, and other clinical disorders
Application:
60/585,735 →
Methods to facilitate transmission of golimumab and other therapeutic molecules across the blood-brain barrier
Application:
60/738,331 →
Methods to facilitate transmission of golimumab and other therapeutic molecules across the blood-brain, blood-eye, and blood-nerve barriers
Application:
60/760,236 →
Methods of perispinal extrathecal administration of large molecules for diagnostic use in mammals
Application:
60/861,153 →
Methods to treat Post-traumatic Stress Disorder utilizing biologics
Application:
61/409,012 →
Methods utilizing biologics for treatment of brain injury
Application:
61/413,440 →
Methods utilizing biologics for treatment of brain injury
Application:
61/413,444 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.